Jeremy Dodge - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Jeremy Dodge's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayJeremy Dodge
Verified
Morning Live Co-Anchor and Host, CFQC-TV (Saskatoon, SK)
Saskatoon
Beats
Content
Saskatoon lab CEO details human trials for Canadian COVID-19 vaccine that doesn't need 'complicated storage'
By Jeremy Dodge Verified| CFQC-TV (Saskatoon, SK) Verified SASKATOON -- As the rollout of a limited supply of Moderna and Pfizer's COVID-19 vaccines continues to gain steam across the country, the University of Saskatchewan's Vaccine and Infectious Disease Organization – International Vaccine Centre (VIDO-InterVac) is expected to start delivering the first doses of its own vaccine candidate this week as part of a recently-approved human clinical trial.
Sask. nurses' union head pitches short-term 'circuit break' lockdown to help turn back tide of new COVID-19 cases
By Jeremy Dodge Verified| CFQC-TV (Saskatoon, SK) Verified SASKATOON -- Saskatchewan Union of Nurses president Tracy Zambory joined CTV News at Five anchor Jeremy Dodge to explain why she thinks the province's new COVID-19 rules don't go nearly far enough and how a novel approach taken in Australia could help stop the spread of coronavirus in Saskatchewan. This interview has been lightly edited for length and clarity. So last week, you spoke to us here at CTV News about some of your concerns.
Saskatoon lab CEO details human trials for Canadian COVID-19 vaccine that doesn't need 'complicated storage'
By Jeremy Dodge Verified| CFQC-TV (Saskatoon, SK) Verified SASKATOON -- As the rollout of a limited supply of Moderna and Pfizer's COVID-19 vaccines continues to gain steam across the country, the University of Saskatchewan's Vaccine and Infectious Disease Organization – International Vaccine Centre (VIDO-InterVac) is expected to start delivering the first doses of its own vaccine candidate this week as part of a recently-approved human clinical trial.
Company Info
CFQC-TV (Saskatoon, SK)